Provided by Tiger Fintech (Singapore) Pte. Ltd.

ResMed

268.09
-1.9100-0.71%
Post-market: 268.090.00000.00%16:55 EDT
Volume:2.28M
Turnover:609.10M
Market Cap:39.13B
PE:28.19
High:270.54
Open:269.04
Low:263.10
Close:270.00
52wk High:293.81
52wk Low:199.92
Shares:145.94M
Float Shares:145.51M
Volume Ratio:2.79
T/O Rate:1.57%
Dividend:2.12
Dividend Rate:0.79%
EPS(TTM):9.51
EPS(LYR):9.55
ROE:25.86%
ROA:14.02%
PB:6.56
PE(LYR):28.08

Loading ...

ResMed CEO Sells Shares

MT Newswires Live
·
Aug 08

Resmed Inc-144 Report of Proposed Sale of Securities

THOMSON REUTERS
·
Aug 08

144 Report of proposed sale of securities-RMD.N

Reuters
·
Aug 08

Statement of changes in beneficial ownership of securities-RMD.N

Reuters
·
Aug 08

Resmed Inc-Statement of Changes in Beneficial Ownership of Securities

THOMSON REUTERS
·
Aug 08

ResMed Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 07

CFO Brett Sandercock Reports Disposal of ResMed Inc. Common Shares

Reuters
·
Aug 06

ResMed Keeps Bull on Margin, Demand Prospects -- Market Talk

Dow Jones
·
Aug 05

ResMed FY2025 Q4 Earnings Call Summary and Q&A Highlights: Operational Efficiency and Digital Innovation Drive Growth

Earnings Call
·
Aug 05

Michael J. Rider, Global General Counsel, Reports Disposal of ResMed Inc. Common Shares

Reuters
·
Aug 05

ResMed CFO, Chief Legal Officer Sells Shares

MT Newswires Live
·
Aug 04

Resmed Inc-144 Report of Proposed Sale of Securities

THOMSON REUTERS
·
Aug 04

144 Report of proposed sale of securities-RMD.N

Reuters
·
Aug 04

Resmed Inc-Departure of Directors or Certain Officers

THOMSON REUTERS
·
Aug 04

Departure of Directors or Certain Officers-RMD.N

Reuters
·
Aug 04

ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast

Reuters
·
Aug 02

ResMed Is Maintained at Overweight by Keybanc

Dow Jones
·
Aug 01

Morgan Stanley Raises Price Target on ResMed to $298 From $291, Keeps Overweight Rating

MT Newswires Live
·
Aug 01

Resmed Inc : Bofa Global Research Raises Price Objective to $300 From $280

THOMSON REUTERS
·
Aug 01

ResMed Inc. Announces Departure of Chief Commercial Officer Bobby Ghoshal for New Role in Non-Competitive Industry

Reuters
·
Aug 01